Skip to main content

Karla V. Resendiz, PharmD, BCPPS, BCCCP

Karla Resendiz, PharmD, BCPPS, BCCCP

Karla V. Resendiz, PharmD, BCPPS, BCCCP

(She/Her)

Karla Resendiz, PharmD, BCPPS, BCCCP, is a residency preceptor with the Pharmacy Residency Program and a clinical pharmacy specialist in Pediatric Critical Care at Children's Hospital of Philadelphia.

Areas of expertise: Sedation, Nutrition support, Pediatric cardiopulmonary resuscitation

Locations: Main Building

About Karla V. Resendiz, PharmD, BCPPS, BCCCP

Titles

Clinical Pharmacy Specialist, Pediatric Critical Care

Pharmacy Residency Program Preceptor

Pharmacy Residency Program Research Committee Co-Chair

Certifications

Board Certified Critical Care Pharmacist (BCCCP)

Board Certified Pediatric Pharmacy Specialist (BCPPS)

Leadership and Memberships

Pediatric Pharmacy Association (PPA): Practice-based Research Networks Subcommittee Co-Chair

Society of Critical Care Medicine (SCCM): Item Writing Committee, ICU Liberation Committee

Research Interests

Sedation Nutrition Support Cardiopulmonary resuscitation

Education & training

Graduate Degree

Doctor of Pharmacy – University of Texas at Austin, Austin, TX 

Residency

Pharmacy Practice (PGY 1) – Children’s National Medical Center, Washington, DC
Pediatric Specialty (PGY 2) – Medical University of South Carolina, Charleston, SC

Team affiliations

View fewer all team affiliations View all all team affiliations

Publications

Publications

2024

Weber MD, Woods-Hill C, Resendiz K, et al. Safety and Efficacy of Ethanol for Catheter Salvage and Central Line-Associated Bloodstream Infection Prophylaxis in Polyurethane Catheters in the PICU. Pediatr Crit Care Med. 2024 May 1;25(5):e232-e238.

Jacobwitz M, Mulvihill C, Kaufman MC, Gonzalez AK, Resendiz K, et al. A Comparison of Ketamine and Midazolam as First-Line Anesthetic Infusions for Pediatric Status Epilepticus. Neurocrit Care. 2024 Jun;40(3):984-995.

2022

Resendiz K. Inhalation Lung Injuries. In: Lee BR, Ohler KH, eds. Pediatric Self-Assessment Program, 2022 Book 1. Critical Care. Lenexa, KS: American College of Clinical Pharmacy, 2022:7-24.

Jacobwitz M, Mulvihill C, Kaufman MC, Gonzalez AK, Resendiz K, et al. Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus. Neurology. 2022; 99(12):e1227-e1238.

2020

Blowey B, Resendiz K, Grachen A et al. Prevention is better than cure: The vital role of the clinical pharmacist in the pediatric intensive care unit to prevent medication errors. J Pediatr Crit Care 2020; 7(5):235

O’Neil ER; Schmees LR; Resendiz K et al. Inhaled Tranexamic Acid As a Novel Treatment for Pulmonary Hemorrhage in Critically Ill Pediatric Patients. Crit Care Explor 2020; 2(1):e0075

Resendiz K, Humlicek TJ, Moffett BS. Drugs. In Mery CM (ed), Texas Children’s Hospital Handbook of Congenital Heart Disease (pp.522-534). Houston, TX: Texas Children’s Hospital, 2020.

Jump back to top